HRT Financial’s M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 MBAC.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding MBAC.WS
HRT Financial's MBAC.WS Position: Q4 2023 in Review
HRT Financial sold out of M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 (MBAC.WS) in Q4 2023, closing a stake of 24,670 shares — an estimated $1K sold.
HRT Financial first reported a position in MBAC.WS in Q1 2022 and held it in 7 quarters. The position peaked at $8K in Q1 2022. 1 fund tracked by Wall St. Rank holds MBAC.WS as of Q4 2023.
- HRT Financial reported no remaining M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position as of Q4 2023 after selling out during the quarter.
- HRT Financial sold 24,670 M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 shares in Q4 2023, an estimated $1K.
- HRT Financial first reported a position in M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 in Q1 2022 and held it in 7 quarters.
- HRT Financial's M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position peaked at $8K in Q1 2022.
- 1 fund tracked by Wall St. Rank held M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 as of Q4 2023.
Based on HRT Financial's 13F filing for Q4 2023, filed 9 Feb 2024.